Michael D. Parkins

6.2k citations

127 papers · 4.2k indexed · h-index 34

Impact in

Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Endocrinology top 1%

Papers in

Molecular Medicine 26
- Antibiotic Resistance in Bacteria 26
Pulmonary and Respiratory Medicine 76
- Cystic Fibrosis Research Advances 71
- Tracheal and airway disorders 18

Co-authors: Michael G. Surette Harvey Rabin Christopher D. Sibley Douglas G. Storey Ranjani Somayaji Kevin B. Laupland Howard Ceri J.S. Elborn
Journals: Journal of Cystic Fibrosis (12 papers)BMC Infectious Diseases (6 papers)Open Forum Infectious Diseases (6 papers)Journal of Clinical Microbiology (5 papers)PLoS ONE (5 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

Michael D. Parkins

123 papers receiving 4.1k citations

Peers

Countries citing papers authored by Michael D. Parkins

Since Specialization

Citations

This map shows the geographic impact of Michael D. Parkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Parkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Parkins more than expected).

Fields of papers citing papers by Michael D. Parkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Parkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Parkins. The network helps show where Michael D. Parkins may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael D. Parkins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael D. Parkins Line = papers co-authored together Michael D. Parkins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis Annals of Medicine ·Mathew P. Estey, Shelby Sissons, Heather Sharpe, Michelle Doll-Shankaruk, Daniel R. Beriault, Julie Gilmour, Kathleen Lee, Winnie M. Leung, Michael D. Parkins, Bradley S. Quon, Elizabeth Tullis, Jie Zheng, Grace Y. Lam	2025	0
2	Longitudinal monitoring of sewershed resistomes in socioeconomically diverse urban neighborhoods Communications Medicine ·Jangwoo Lee, Kevin Xiang, Emily Au, Shahrzad Sarabi, Nicole Acosta, Srijak Bhatnagar, Jennifer Van Doorn, Stefania Bertazzon, John Conly, Elissa Rennert‐May, Johann Pitout, Bonita E. Lee, Xiaoli Pang, Christine O’Grady, Kevin J. Frankowski, Casey R. J. Hubert, Michael D. Parkins	2025	1
3	Bronchoscopic Removal of Recurrent, Bilateral Aspergillomas in a Person With Cystic Fibrosis (Pwcf) Who Underwent Double Lung Transplant With Polymicrobial Pulmonary Colonization and a Trial of Preprocedural Antibiotics Kathryn M. Lalonde, Christina S. Thornton, Paul MacEachern, J. Liu, Douglas Helmersen, Michael D. Parkins, Elaine Dumoulin	2024	1
4	Early warning COVID-19 outbreak in long-term care facilities using wastewater surveillance: correlation, prediction, and interaction with clinical and serological statuses The Lancet Microbe ·Xiaoli Pang, Bonita E. Lee, Tiejun Gao, Rhonda J. Rosychuk, Linnet Immaraj, Judy Qiu, Jiabi Wen, Nathan Zelyas, Krista Howden, Janelle Wallace, Eleanor Risling, Lorie A. Little, John Kim, Heidi Wood, Alyssia Robinson, Michael D. Parkins, Casey R. J. Hubert, Kevin J. Frankowski, Steve E. Hrudey, Christopher Sikora	2024	2
5	Evaluating Sinus Microbiology by Transplant Status in Persons With Cystic Fibrosis: A Matched Cohort Study OTO Open ·Ranjani Somayaji, Christina S. Thornton, Nicole Acosta, Kristine A. Smith, Jessica Clark, Linda Fatovich, Mitesh V. Thakrar, Michael D. Parkins	2024	1
6	The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident Stenotrophomonas maltophilia infection Frontiers in Microbiology ·Lauren A. Bowron, Nicole Acosta, Christina S. Thornton, Jennifer Carpentero, Barbara-Jean M. Waddell, Lalit M. Bharadwaj, Kirsten Ebbert, Daniel Castañeda-Mogollón, John Conly, Harvey Rabin, Michael G. Surette, Michael D. Parkins	2024	1
7	A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment European Respiratory Journal ·Valerie Waters, Michelle Shaw, Lucy Perrem, Bradley S. Quon, Elizabeth Tullis, Melinda Solomon, Jonathan H. Rayment, Annick Lavoie, Sze Man Tse, Patrick Daigneault, Lara Bilodeau, April Price, Michael Nicholson, Melanie Chin, Michael D. Parkins, Martha L. McKinney, Julian S. Tam, Sanja Stanojevic, Hartmut Grasemann, Félix Ratjen, (unknown)	2024	5
8	Single nucleotide variants in Pseudomonas aeruginosa populations from sputum correlate with baseline lung function and predict disease progression in individuals with cystic fibrosis Microbial Genomics ·Morteza M. Saber, Jannik Donner, Inès Levade, Nicole Acosta, Michael D. Parkins, Brian Boyle, Roger C. Lévesque, Dao Nguyen, B. Jesse Shapiro	2023	2
9	Quantitative Evaluation of Municipal Wastewater Disinfection by 280 nm UVC LED Water ·Linlong Yu, Nicole Acosta, María A. Bautista, Janine McCalder, Jode Himann, Samuel Pogosian, Casey R. J. Hubert, Michael D. Parkins, Gopal Achari	2023	7
10	Incidence, susceptibility and outcomes of candidemia in adults living in Calgary, Alberta, Canada (2010–2018) BMC Infectious Diseases ·Samuel Bourassa‐Blanchette, Marit M. Biesheuvel, John C. Lam, Alexander Kipp, Deirdre L. Church, Julie Carson, Bruce Dalton, Michael D. Parkins, Herman W. Barkema, Daniel B. Gregson	2023	10
11	Stenotrophomonas maltophilia natural history and evolution in the airways of adults with cystic fibrosis Frontiers in Microbiology ·Conrad Izydorczyk, Barbara J. Waddell, Christina S. Thornton, John Conly, Harvey Rabin, Ranjani Somayaji, Michael G. Surette, Deirdre L. Church, Michael D. Parkins	2023	2
12	The natural history and genetic diversity of Haemophilus influenzae infecting the airways of adults with cystic fibrosis Scientific Reports ·Conrad Izydorczyk, Barbara J. Waddell, R. Benson Weyant, Michael G. Surette, Ranjani Somayaji, Harvey Rabin, John Conly, Deirdre L. Church, Michael D. Parkins	2022	4
13	Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic BMC Pulmonary Medicine ·Hannah R. Mathew, May Y. Choi, Michael D. Parkins, Marvin J. Fritzler	2021	32
14	Sputum microbiota in adults with CF associates with response to inhaled tobramycin Thorax ·Alya Heirali, Christina S. Thornton, Nicole Acosta, Ranjani Somayaji, Isabelle Laforest‐Lapointe, Douglas G. Storey, Harvey Rabin, Barbara J. Waddell, Laura Rossi, Marie‐Claire Arrieta, Michael G. Surette, Michael D. Parkins	2020	17
15	Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study BMC Pulmonary Medicine ·Christina S. Thornton, Erin L. Brown, Joenel Alcantara, Harvey Rabin, Michael D. Parkins	2015	5
16	Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient PLoS ONE ·Matthew L. Workentine, Christopher D. Sibley, Bryan A. Glezerson, Swathi Purighalla, Jens C. Norgaard-Gron, Michael D. Parkins, Harvey Rabin, Michael G. Surette	2013	145
17	A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients Proceedings of the National Academy of Sciences ·Christopher D. Sibley, Michael D. Parkins, Harvey Rabin, Kangmin Duan, Jens Christian Nørgaard, Michael G. Surette	2008	262
18	Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections Journal of Antimicrobial Chemotherapy ·Michael D. Parkins, Deana Sabuda, Sameer Elsayed, Kevin B. Laupland	2007	177
19	Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐ResistantPseudomonas aeruginosain the Calgary Health Region: Importance of Metallo‐β‐Lactamase (MBL)–Producing Strains The Journal of Infectious Diseases ·Kevin B. Laupland, Michael D. Parkins, Deirdre L. Church, Daniel B. Gregson, Thomas Louie, John Conly, Sameer Elsayed, Johann Pitout	2005	91
20	Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation Molecular Microbiology ·Michael D. Parkins, Howard Ceri, Douglas G. Storey	2001	185

About Michael D. Parkins

Michael D. Parkins is a scholar working on Molecular Medicine, Pulmonary and Respiratory Medicine, Applied Microbiology and Biotechnology, Endocrinology and Clinical Biochemistry, having authored 127 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (71 papers), Antibiotic Resistance in Bacteria (26 papers), Bacterial biofilms and quorum sensing (20 papers), Pneumonia and Respiratory Infections (19 papers), Tracheal and airway disorders (18 papers), Gut microbiota and health (12 papers), Bacterial Identification and Susceptibility Testing (11 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). The work is most often cited by research in Molecular Medicine (857 citations), Endocrinology (497 citations), Applied Microbiology and Biotechnology (173 citations), Pulmonary and Respiratory Medicine (1.8k citations) and Clinical Biochemistry (364 citations). Michael D. Parkins has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Michael G. Surette, Harvey Rabin, Christopher D. Sibley, Douglas G. Storey, Ranjani Somayaji, Kevin B. Laupland, Howard Ceri, J.S. Elborn, R. Andres Floto and Kangmin Duan. Their work appears in journals such as Journal of Cystic Fibrosis, BMC Infectious Diseases, Open Forum Infectious Diseases, Journal of Clinical Microbiology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact